Ferring Pharmaceuticals Inc recalls Bravelle 75 IU (urofollitropin for injection, purified) For Subcutaneous or Intramuscular Injection Only, 1 Carton (cont
Recalled October 21, 2015 · FDA recall D-0015-2016 · Ferring Pharmaceuticals
Hazard
Subpotent Drug · FDA Class III
Units
32,341 vials
Sold at
Nationwide
Description
Subpotent Drug
Product
Bravelle 75 IU (urofollitropin for injection, purified) For Subcutaneous or Intramuscular Injection Only, 1 Carton (contains 5 single dose vials of Bravelle, 5 single dose vials of 0.9% Sodium Chloride Inj., USP, 2 mL, and 5 Q-Cap Vial Adaptors) , Rx Only, Manufactured for: Ferring Pharmaceuticals, Inc. Parsippany, NJ 07054, By: Ferring Gmbh, Kiel Germany, NDC 55566-8505-6
Manufacturer(s)
Ferring Pharmaceuticals Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →